Should I buy Ameren (AEE) stock or is it too late?
⭐ The most reliable of them, either direction: Barclays — 73% of its targets hit on this sector (313 calls tested). It aims for $117 (+9.6 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).
Firm-by-firm track record on Ameren
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| UBS | 100 % | +16.1 % | 7 | $127 +19% |
| Barclays | 83 % | +12.7 % | 6 | $117 +10% |
| BMO Capital | 78 % | +11.4 % | 18 | $119 +11% |
| Keybanc | 60 % | +4.7 % | 5 | $122 +14% |
| Wells Fargo | 56 % | +2.7 % | 16 | $113 +6% |
| JP Morgan | 50 % | -1.8 % | 6 | $137 +28% |
| Morgan Stanley | 45 % | -4.1 % | 11 | $114 +7% |
| B of A Securities | 38 % | -1.1 % | 8 | — |
✅ Reasons to believe
- 75% of analysts rate it a buy (Buy consensus, 8 ratings) — a sign of market conviction.
- Median price target $120, i.e. +12% from the current price ($107).
- The most reliable firm on AEE, UBS (100% hit rate, 7 scored calls), targets $127 (call made on February 20, 2026, maturing on February 20, 2027) (+19%) in its most recent call, and $115 (call made on December 17, 2025, maturing on December 17, 2026) (+8%) in the one coming due soonest.
- Pays a dividend (2.6% yield), raised for 12 years — regular income on top of potential upside.
- Reasonable valuation (P/E ~19) relative to its sector.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 8 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on AEE
Median target $120 (+12%) · 8 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Ameren now?
We won't decide for you. The facts: 75% of analysts rate it a buy, median target $120 (+12%), and UBS (most reliable on AEE, 100%) targets $127. Weigh that against valuation (P/E ~19). This is not personalized advice.
Is it too late to invest in Ameren?
Not according to analysts: the median target ($120) is still +12% above the current price ($107) (most reliable on AEE: UBS, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Ameren still worth investing in?
It depends on the gap between the price ($107) and its estimated value: analysts target $120 on median (+12%), with 75% buys (most reliable on AEE: UBS, 100%). Cross-check with their real reliability on AEE and the cautions above. Information, not advice.
What's the main risk in buying AEE?
The consensus is not unanimous: of 8 ratings, 2 are neutral.
→ Go deeper: the full Ameren profile (consensus, analyst reliability, price target, performance).